Three years treatment with either sublingual or subcutaneous allergen immunotherapy has been shown to be effective and to induce long-term tolerance. The GRASS∗ trial demonstrated that two years treatment via either route was effective in suppressing the response to nasal allergen challenge, although was insufficient for inhibition one year after discontinuation.
http://ift.tt/2zGvZj7
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου